NEW YORK (GenomeWeb News) - Molecular Devices’ shares surged 47 percent in afternoon trading to $35.05 from Friday’s close of $23.38, in the wake of this morning’s announcement that the company will be bought by MDS.
MDS said earlier today that it will pay $615 million in cash for Molecular Devices and combine the firm with its MDS Sciex business.
MDS’ stock was up 1.17 percent to $17.30.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.